Nationwide Fund Advisors’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-23,161
| Closed | -$793K | – | 1854 |
|
|
2017
Q3 | $793K | Sell |
23,161
-460
| -2% | -$15.8K | ﹤0.01% | 1930 |
|
|
2017
Q2 | $941K | Sell |
23,621
-27
| -0.1% | -$1.08K | ﹤0.01% | 1813 |
|
|
2017
Q1 | $871K | Sell |
23,648
-817
| -3% | -$30.1K | ﹤0.01% | 1845 |
|
|
2016
Q4 | $780K | Buy |
24,465
+770
| +3% | +$24.5K | ﹤0.01% | 1919 |
|
|
2016
Q3 | $859K | Sell |
23,695
-4,896
| -17% | -$177K | ﹤0.01% | 1881 |
|
|
2016
Q2 | $649K | Buy |
28,591
+10,059
| +54% | +$228K | ﹤0.01% | 2001 |
|
|
2016
Q1 | $348K | Buy |
18,532
+422
| +2% | +$7.92K | ﹤0.01% | 2275 |
|
|
2015
Q4 | $297K | Buy |
18,110
+1,741
| +11% | +$28.6K | ﹤0.01% | 2359 |
|
|
2015
Q3 | $180K | Hold |
16,369
| – | – | ﹤0.01% | 2615 |
|
|
2015
Q2 | $213K | Sell |
16,369
-860
| -5% | -$11.2K | ﹤0.01% | 2681 |
|
|
2015
Q1 | $299K | Sell |
17,229
-563
| -3% | -$9.77K | ﹤0.01% | 2496 |
|
|
2014
Q4 | $265K | Sell |
17,792
-288
| -2% | -$4.29K | ﹤0.01% | 2502 |
|
|
2014
Q3 | $417K | Sell |
18,080
-36
| -0.2% | -$830 | ﹤0.01% | 2315 |
|
|
2014
Q2 | $578K | Buy |
+18,116
| New | +$578K | ﹤0.01% | 2182 |
|